More about

Schizophrenia

News
June 10, 2020
2 min read
Save

Adjunctive pimavanserin may improve negative schizophrenia symptoms

Adjunctive pimavanserin may improve negative schizophrenia symptoms

Adjunctive pimavanserin significantly improved outcomes among patients with predominant negative symptoms of schizophrenia, according to data presented at the American Society of Clinical Psychopharmacology Annual Meeting.

News
June 09, 2020
2 min read
Save

KarXT appears effective, safe among hospitalized patients with schizophrenia

An antipsychotic with a novel mechanism of action appeared effective and safe among hospitalized patients with schizophrenia, according to data presented at the American Society of Clinical Psychopharmacology Annual Meeting.

News
May 29, 2020
2 min read
Save

Long-acting antipsychotics safe, effective for in-hospital schizophrenia therapy initiation

Long-acting antipsychotics safe, effective for in-hospital schizophrenia therapy initiation

Aristada Initio and Invega Sustenna appeared well tolerated and effective for initiating in-hospital schizophrenia treatment and continuing outpatient treatment, according to a study published in Journal of Clinical Psychiatry.

News
May 28, 2020
3 min read
Save

ALKS 3831 appears safe, well tolerated as long-term schizophrenia treatment

ALKS 3831 appears safe, well tolerated as long-term schizophrenia treatment

A combination of olanzapine and samidorphan was well tolerated and not associated with new safety risks compared with olanzapine alone, according to data presented during the Virtual 2020 Schizophrenia International Research Society Congress.

News
May 26, 2020
3 min read
Save

Ketamine may cause psychosis-like symptoms among healthy individuals

Ketamine appeared associated with psychosis-like symptoms among healthy individuals, according to results of a systematic review and meta-analysis published in JAMA Network Open.

News
May 12, 2020
1 min read
Save

Top stories to read during Mental Health Awareness Month 2020

The Mental Health America organization has designated each May as Mental Health Awareness Month.

News
April 13, 2020
2 min read
Save

Prenatal and perinatal factors linked to later psychosis onset

Prenatal and perinatal factors linked to later psychosis onset

Researchers have uncovered several prenatal and perinatal factors associated with later psychosis onset, according to results of a systematic review and meta-analysis published in The Lancet Psychiatry.

News
April 07, 2020
2 min read
Save

Olanzapine may be more effective than other antipsychotics for patients with schizophrenia, alcohol use disorder

Patients with schizophrenia and alcohol use disorder experienced a worse illness course than those with only schizophrenia, according to results of a post hoc analysis published in Journal of Clinical Psychiatry.

News
April 06, 2020
2 min read
Save

Early monitoring of metabolic traits among patients on antipsychotics may reduce adverse effects

Clinicians should frequently monitor metabolic traits during early stages of antipsychotic treatment because of rapid and substantial changes that can occur, according to results of a randomized, open-label, pharmacologic trial published in Journal of Clinical Psychiatry.

News
March 25, 2020
2 min read
Save

ALKS 3831 not superior to olanzapine alone for delaying schizophrenia, alcohol use disorder symptom exacerbation

A combination of olanzapine and samidorphan was not superior to olanzapine alone in the time to first event of exacerbation of disease symptoms in patients with schizophrenia and alcohol use disorder, according to results of a phase 2, randomized clinical trial published in Journal of Clinical Psychiatry.

View more